BlueRun Ventures Leads SiranBio's Nearly 400 Million Yuan Series A Financing to Accelerate siRNA Dual-Target and Extrahepatic Delivery Pipeline | BlueRun Ventures
Shi'an's Dual-Target Platform and Extracorporeal Liver Delivery System: A Dual-Wheel Innovation Engine









